Search Results - "Simpson, Jean F."

Refine Results
  1. 1

    Continued observation of the natural history of low-grade ductal carcinoma in situ reaffirms proclivity for local recurrence even after more than 30 years of follow-up by Sanders, Melinda E, Schuyler, Peggy A, Simpson, Jean F, Page, David L, Dupont, William D

    Published in Modern pathology (01-05-2015)
    “…Opportunities to study the natural history of ductal carcinoma in situ are rare. A few studies of incompletely excised lesions in the premammographic era,…”
    Get full text
    Journal Article
  2. 2

    Prognostic Factors in Breast Cancer by Fitzgibbons, Patrick L, Page, David L, Weaver, Donald, Thor, Ann D, Allred, D. Craig, Clark, Gary M, Ruby, Stephen G, O'Malley, Frances, Simpson, Jean F, Connolly, James L, Hayes, Daniel F, Edge, Stephen B, Lichter, Allen, Schnitt, Stuart J

    “…Abstract Background.—Under the auspices of the College of American Pathologists, a multidisciplinary group of clinicians, pathologists, and statisticians…”
    Get full text
    Journal Article
  3. 3

    Metaplastic Spindle Cell Breast Tumors Arising within Papillomas, Complex Sclerosing Lesions, and Nipple Adenomas by Gobbi, Helenice, Simpson, Jean F, Jensen, Roy A, Olson, Sandra J, Page, David L

    Published in Modern pathology (01-09-2003)
    “…Micropapillomas/papillomas and complex sclerosing lesions of the breast have been associated with a slightly increased risk for subsequent carcinoma, although…”
    Get full text
    Journal Article
  4. 4

    Neoadjuvant Concurrent Paclitaxel and Radiation in Stage II/III Breast Cancer by CHAKRAVARTHY, A. Bapsi, KELLEY, Mark C, JONES, Catherine, PIETENPOL, Jennifer A, MCLAREN, Bernadette, TRUICA, Cristina I, BILLHEIMER, Dean, MAYER, Ingrid A, GRAU, Ana M, JOHNSON, David H, SIMPSON, Jean F, BEAUCHAMP, R. Daniel

    Published in Clinical cancer research (01-03-2006)
    “…Purpose: The aim of this study was to determine the safety and pathologic response rates following neoadjuvant paclitaxel and radiation in patients with stage…”
    Get full text
    Journal Article
  5. 5

    Artifactual Displacement of Ductal Carcinoma In Situ (ADDCIS) (Toothpaste Effect): A Mimicker of Invasive Ductal Carcinoma by Shabihkhani, Maryam, Simpson, Jean F., White, Marissa J., Cimino-Mathews, Ashley, Argani, Pedram

    Published in The American journal of surgical pathology (01-01-2020)
    “…Needle tract displacement is a recognized mimicker of invasive ductal carcinoma (IDC). Artifactual displacement of ductal carcinoma in situ (ADDCIS)…”
    Get full text
    Journal Article
  6. 6

    Blockade of the Epidermal Growth Factor Receptor Tyrosine Kinase Suppresses Tumorigenesis in MMTV/Neu + MMTV/TGF-α Bigenic Mice by Anne E. G. Lenferink, Simpson, Jean F., Shawver, Laura K., Coffey, Robert J., Forbes, James T., Arteaga, Carlos L.

    “…Overexpression of ErbB-2/Neu has been causally associated with mammary epithelial transformation. Here we report that blockade of the epidermal growth factor…”
    Get full text
    Journal Article
  7. 7

    Liposarcomatous differentiation in malignant phyllodes tumours is unassociated with MDM2 or CDK4 amplification by Lyle, Pamela L, Bridge, Julia A, Simpson, Jean F, Cates, Justin M, Sanders, Melinda E

    Published in Histopathology (01-06-2016)
    “…Aims Breast sarcomas are rare, usually occurring in the setting of malignant phyllodes tumour (MPT). Heterologous differentiation commonly resembles…”
    Get full text
    Journal Article
  8. 8

    Update on atypical epithelial hyperplasia and ductal carcinoma in situ by Simpson, Jean F.

    Published in Pathology (01-01-2009)
    “…Atypical ductal hyperplasia (ADH) as an indicator of increased risk for developing breast cancer is well established. Refinement in its molecular…”
    Get full text
    Journal Article
  9. 9

    Epidermal growth factor receptor (HER1) tyrosine kinase inhibitor ZD1839 (Iressa) inhibits HER2/neu (erbB2)-overexpressing breast cancer cells in vitro and in vivo by MOULDER, Stacy L, YAKES, F. Michael, MUTHUSWAMY, Senthil K, BIANCO, Roberto, SIMPSON, Jean F, ARTEAGA, Carlos L

    Published in Cancer research (Chicago, Ill.) (15-12-2001)
    “…Aberrrant signaling by the epidermal growth factor receptor [EGFR (HER1, erbB1)] and/or HER2/neu tyrosine kinases is present in a cohort of breast carcinomas…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Atypical lobular hyperplasia as a unilateral predictor of breast cancer risk: a retrospective cohort study by Page, David L, Schuyler, Peggy A, Dupont, William D, Jensen, Roy A, Plummer, W Dale, Simpson, Jean F

    Published in The Lancet (British edition) (11-01-2003)
    “…Clinical decisions about atypical lobular hyperplasia are based on the belief that later invasive breast-cancer risk is equal in both breasts. We aimed to show…”
    Get full text
    Journal Article
  12. 12

    Histologic Associations and Long-term Cancer Risk in Columnar Cell Lesions of the Breast : A Retrospective Cohort and a Nested Case-Control Study by BOULOS, Fouad I, DUPONT, William D, SIMPSON, Jean F, SCHUYLER, Peggy A, SANDERS, Melinda E, FREUDENTHAL, Marcia E, PAGE, David L

    Published in Cancer (01-11-2008)
    “…Mammary columnar cell lesions with atypia have been receiving increased scrutiny in view of their association with atypical hyperplasia (AH) and carcinoma…”
    Get full text
    Journal Article
  13. 13

    Differential Diagnosis of Proliferative Breast Lesions by Simpson, Jean F., MD, Boulos, Fouad I., MD

    Published in Surgical pathology clinics (01-06-2009)
    “…Abstract The correct diagnosis of proliferations within the mammary terminal duct-lobular unit has paramount prognostic and therapeutic implications…”
    Get full text
    Journal Article
  14. 14

    Selective use of intraoperative touch prep analysis of sentinel nodes in breast cancer by Forbes, Rachel C, Pitchford, Clovis, Simpson, Jean F, Balch, Glen C, Kelley, Mark C

    Published in The American surgeon (01-11-2005)
    “…Imprint cytology (touch prep) is often used for intraoperative examination of sentinel nodes in breast cancer. This allows axillary lymph node dissection…”
    Get more information
    Journal Article
  15. 15

    Inhibition of HER2/neu (erbB-2) and mitogen-activated protein kinases enhances tamoxifen action against HER2-overexpressing, tamoxifen-resistant breast cancer cells by KUROKAWA, Hirokazu, LENFERINK, Anne E. G, SIMPSON, Jean F, PISACANE, Paul I, SLIWKOWSKI, Mark X, FORBES, James T, ARTEAGA, Carlos L

    Published in Cancer research (Chicago, Ill.) (15-10-2000)
    “…HER2/neu (erbB-2) overexpression has been causally associated with tamoxifen resistance in human breast cancer cells. Forced expression of HER2 in MCF-7 breast…”
    Get full text
    Journal Article
  16. 16

    Intranodal Papillary Epithelial Proliferations: A Local Process With a Spectrum of Morphologies and Frequent Association With Papillomas in the Breast by Boulos, Fouad I., Granja, Nara M., Simpson, Jean F., O’Malley, Frances P., Saadeldine, Mothana M., Page, David L., Sanders, Melina E.

    Published in The American journal of surgical pathology (01-03-2014)
    “…Lymph nodes, particularly those draining in major anatomic sites like axilla, pelvis, and neck are potential sites for the occasional presence of ectopic…”
    Get full text
    Journal Article
  17. 17

    Interdependence of radial scar and proliferative disease with respect to invasive breast carcinoma risk in patients with benign breast biopsies by Sanders, Melinda E., Page, David L., Simpson, Jean F., Schuyler, Peggy A., Dale Plummer, W., Dupont, William D.

    Published in Cancer (01-04-2006)
    “…BACKGROUND Radial scars (RS) are benign breast lesions that have been implicated as independent risk factors for invasive breast carcinoma (IBC). METHODS A…”
    Get full text
    Journal Article
  18. 18

    Definitive Diagnosis for High-Risk Breast Lesions Without Open Surgical Excision: The Intact Percutaneous Excision Trial (IPET) by Whitworth, Pat W., Simpson, Jean F., Poller, William R., Schonholz, Steven M., Turner, John F., Phillips, Rogsbert F., Johnson, Joel M., McEachin, F. David

    Published in Annals of surgical oncology (01-10-2011)
    “…Background Open surgical excision (OSE) is generally recommended when image-guided core-needle breast biopsy demonstrates a high-risk lesion (HRL). We…”
    Get full text
    Journal Article
  19. 19

    Clinicopathologic Characteristics of Carcinomas That Develop After a Biopsy Containing Columnar Cell Lesions: Evidence Against a Precursor Role by BOULOS, Fouad I, DUPONT, William D, SCHUYLER, Peggy A, SANDERS, Melinda E, PAGE, David L, FEDDA, Faysal A, SIMPSON, Jean F

    Published in Cancer (01-05-2012)
    “…Columnar cell lesions are frequently associated with atypical ductal hyperplasia, lobular neoplasia, and tubular carcinoma, and have been suggested as a…”
    Get full text
    Journal Article
  20. 20